Literature DB >> 33854672

Human papillomavirus, gene mutation and estrogen and progesterone receptors in breast cancer: a cross-sectional study.

Abdallah Mohammed Elagali1,2, Ahmed Abdelbadie Suliman3, Mohammed Altayeb1,4, Anas Ibrahim Dannoun4, Narasimha Reddy Parine5, Hader Ibrahim Sakr6, Howayda Saeed Suliman7, Moustafa Elsaeid Motawee8.   

Abstract

INTRODUCTION: recent studies show a good relationship between breast cancer (BC) and human papillomaviruses (HPV) wich is responsible for about 18% of BC cases. This study aimed to assess the relationship between different genotypes of HPV and the expression of P53 and retinoblastoma (RB) genes and estrogen and progesterone receptors in BC among Sudanese women.
METHODS: one hundred and fifty tissue blocks were obtained from females diagnosed with BC. Positive samples were used to determine genotypes with an applied biosystem (ABI 3730XL) genetic analyzer for sequencing and immunohistochemistry.
RESULTS: 13/150 samples showed HPV DNA. High-risk HPV-16 was detected in 5 cases, high-risk-HPV-58 was found in four cases, and HPV-18 was detected in three cases. Low-risk-HPV-11 was detected in a single invasive lobular carcinoma (ILC) case. P53 and RB gene mutations were detected in 35 and 30 BC cases, respectively. P53 gene mutation was frequently identified in grade (III) BC while RB gene mutation was positive in grade (II). Grade (II) BC had a higher incidence of HPV-16 and 58. On the other hand, HPV-18 had a higher incidence in grade (III). Estrogen and progesterone receptors were expressed in 94 and 79 HPV cases among the study group, respectively.
CONCLUSION: this study elucidates the associations between HPV genotypes and BC. A statistically significant association was observed among p53 and RB gene mutations and different BC histological types. On the other hand, there was a statistically insignificant association between HPV genotyping and different BC gradings, BC histological types, P53 and RB genes mutations, and estrogen and progesterone receptor expression. Also, there was a statistically insignificant association among estrogen and progesterone receptors expression and BC grading. RB gene mutation was significantly associated with different BC grades. On the other hand, there was a statistically insignificant association between progesterone receptor expression and BC. Copyright: Abdallah Mohammed Elagali et al.

Entities:  

Keywords:  Breast cancer; estrogen receptors; human papillomavirus; invasive lobular carcinoma; p53 gene; progesterone receptors; retinoblastoma gene

Mesh:

Substances:

Year:  2021        PMID: 33854672      PMCID: PMC8017370          DOI: 10.11604/pamj.2021.38.43.22013

Source DB:  PubMed          Journal:  Pan Afr Med J


  43 in total

1.  Minor role for BRCA2 (exon11) and p53 (exon 5-9) among Sudanese breast cancer patients.

Authors:  M A Masri; N M Abdel Seed; A H Fahal; M Romano; F Baralle; A M El Hassam; M E Ibrahim
Journal:  Breast Cancer Res Treat       Date:  2002-01       Impact factor: 4.872

2.  Viral load and integration status of high-risk human papillomaviruses in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.

Authors:  Bin Wang; Shanmugarajah Rajendra; Darren Pavey; Prateek Sharma; Neil Merrett; Xiaojuan Wu; Elizabeth T Snow; Vivek Kumbhari; Madeleine J Ball; Iain K Robertson
Journal:  Am J Gastroenterol       Date:  2013-11       Impact factor: 10.864

3.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments.

Authors:  Hans-Ulrich Bernard; Robert D Burk; Zigui Chen; Koenraad van Doorslaer; Harald zur Hausen; Ethel-Michele de Villiers
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

4.  Association of human papillomavirus type 58 with breast cancer in Shaanxi province of China.

Authors:  Ling Fu; Depu Wang; Walayat Shah; Yili Wang; Guanjun Zhang; Jianjun He
Journal:  J Med Virol       Date:  2015-02-09       Impact factor: 2.327

Review 5.  p53 in breast cancer subtypes and new insights into response to chemotherapy.

Authors:  Philippe Bertheau; Jacqueline Lehmann-Che; Mariana Varna; Anne Dumay; Brigitte Poirot; Raphaël Porcher; Elisabeth Turpin; Louis-François Plassa; Anne de Roquancourt; Edwige Bourstyn; Patricia de Cremoux; Anne Janin; Sylvie Giacchetti; Marc Espié; Hugues de Thé
Journal:  Breast       Date:  2013-08       Impact factor: 4.380

Review 6.  Lobular breast cancer: incidence and genetic and non-genetic risk factors.

Authors:  Laure Dossus; Patrick R Benusiglio
Journal:  Breast Cancer Res       Date:  2015-03-13       Impact factor: 6.466

Review 7.  Human Papilloma Viruses and Breast Cancer - Assessment of Causality.

Authors:  James Sutherland Lawson; Wendy K Glenn; Noel James Whitaker
Journal:  Front Oncol       Date:  2016-09-29       Impact factor: 6.244

8.  Prevalence of human papilloma virus among women with breast cancer since 2005-2009 in Isfahan.

Authors:  Leila Manzouri; Rasoul Salehi; Shervin Shariatpanahi; Parisa Rezaie
Journal:  Adv Biomed Res       Date:  2014-01-27

Review 9.  Human papillomavirus-associated cancers: A growing global problem.

Authors:  Anshuma Bansal; Mini P Singh; Bhavana Rai
Journal:  Int J Appl Basic Med Res       Date:  2016 Apr-Jun

10.  Human Papilloma Viruses and Breast Cancer.

Authors:  James S Lawson; Wendy K Glenn; Daria Salyakina; Warick Delprado; Rosemary Clay; Annika Antonsson; Benjamin Heng; Shingo Miyauchi; Dinh D Tran; Christopher C Ngan; Louise Lutze-Mann; Noel J Whitaker
Journal:  Front Oncol       Date:  2015-12-16       Impact factor: 6.244

View more
  1 in total

1.  Presence of Human Papillomavirus DNA in Malignant Neoplasia and Non-Malignant Breast Disease.

Authors:  Erika Maldonado-Rodríguez; Marisa Hernández-Barrales; Adrián Reyes-López; Susana Godina-González; Perla I Gallegos-Flores; Edgar L Esparza-Ibarra; Irma E González-Curiel; Jesús Aguayo-Rojas; Adrián López-Saucedo; Gretel Mendoza-Almanza; Jorge L Ayala-Luján
Journal:  Curr Issues Mol Biol       Date:  2022-08-13       Impact factor: 2.976

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.